Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Kalaris Therapeutics Inc (KLRS)

Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Kalaris Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent diseases of the retina. Kalaris Therapeutics Inc., formerly known as AlloVir Inc., is based in PALO ALTO, Calif.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020
Sales 0 0 0 0 0
Sales Growth unch unch unch unch -100.00%
Net Income -58,770 -190,420 -168,710 -171,960 -69,780
Net Income Growth +69.14% -12.87% +1.89% -146.43% -192.70%

Balance Sheet

(Values in U.S. Thousands) Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020
Total Assets 118,550 190,800 277,080 286,590 370,820
Total Assets Growth -37.87% -31.14% -3.32% -22.71% +165.97%
Total Liabilities 5,240 45,020 52,560 61,330 17,760
Total Liabilities Growth -88.36% -14.35% -14.30% +245.33% -90.70%

Cash Flow

(Values in U.S. Thousands) Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021 Dec, 2020
Operating Cash Flow -67,710 -124,450 -142,050 -106,320 -60,810
Operating Cash Flow Growth +45.59% +12.39% -33.61% -74.84% -201.64%
Net Cash Flow 27,320 -15,970 -95,570 79,850 61,580
Change in Net Cash Flow +271.07% +83.29% -219.69% +29.67% +70.49%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot